Skip to main content
IC
CureVac N.V. (ETR:5CV)
Germany flag Germany · Delayed Price · Currency is EUR
3.256
+0.036 (1.12%)
May 13, 2025, 5:35 PM CET

CureVac Revenue

In the year 2024, CureVac had annual revenue of 535.18M EUR with 895.54% growth. CureVac had revenue of 254.19M in the quarter ending December 31, 2024, with 1,026.36% growth.

Revenue
535.18M
Revenue Growth
+895.54%
P/S Ratio
1.37
Revenue / Employee
592.01K
Employees
983
Market Cap
732.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024535.18M481.42M895.54%
Dec 31, 202353.76M-13.66M-20.26%
Dec 31, 202267.42M-35.57M-34.54%
Dec 31, 2021102.99M54.12M110.74%
Dec 31, 202048.87M31.46M180.61%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.14B
Merck KGaA 21.16B
Fresenius SE & Co. KGaA 22.13B
Bayer Aktiengesellschaft 46.61B
Fresenius Medical Care AG 19.49B
Sartorius Aktiengesellschaft 3.44B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.33B
Revenue Rankings

CureVac News

More News